Brief: Jasper Therapeutics Appoints Jeet Mahal As Chief Executive Officer To Lead Next Phase Of Clinical Growth
07/01/2026 22:19
Jan 8 (Reuters) - Jasper Therapeutics Inc JSPR.O: JASPER THERAPEUTICS APPOINTS JEET MAHAL AS CHIEF EXECUTIVE OFFICER TO LEAD NEXT PHASE OF CLINICAL GROWTH JASPER THERAPEUTICS INC - THOMAS WIGGANS APPOINTED AS EXECUTIVE CHAIRPERSON OF JASPER Source text: ID:nGNX8X63js Further company coverage: JSPR.O ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Jasper Therapeutics
See all newsBrief: Jasper Therapeutics Announces Commencement Of An Offer To Purchase Outstanding Warrants
Jasper Therapeutics, Inc. reports results for the quarter ended June 30 - Earnings Summary
Jasper Therapeutics Q2 loss per share beats estimates, raises $132 mln
Jasper Therapeutics, Inc. expected to post a loss of 35 cents a share - Earnings Preview
Jasper Therapeutics rises; co announces all-stock merger with Kira Pharma